Overview

A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate a daily dose of BLI400 Laxative for safety and efficacy versus lubiprostone in constipated adults.
Phase:
Phase 3
Details
Lead Sponsor:
Braintree Laboratories
Treatments:
Cathartics
Laxatives
Lubiprostone